GlassScriptPhysician profile
Heidi M Crane
NPI 1700962560
$37,997.35
in general payments reported to CMS, 2019-2025
4 companies · $2,337 in 2025
The $2,337 reported for 2025 was more than what 86% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,382 · 2020: $11K · 2022: $15K · 2025: $2,337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,743 · Food and Beverage: $595.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,742.70 |
| Food and Beverage | $594.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $16,010.88 | 2019-2025 | |
| Gilead Sciences, INC. | $14,913.20 | 2020-2022 | |
| Theratechnologies INC. | $5,948.27 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $1,125.00 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Crane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.